中国卫生产业
中國衛生產業
중국위생산업
CHINA HEALTH INDUSTRY
2014年
16期
19-20
,共2页
尿酸%缺血性脑血管病%预后%影响
尿痠%缺血性腦血管病%預後%影響
뇨산%결혈성뇌혈관병%예후%영향
Uric acid%Ischemic cerebrovascular disease%Prognosis%Influence
目的:探讨降尿酸治疗对缺血性脑血管病预后的影响。方法从本院2010年10月-2012年10月收治的缺血性脑血管病患者中随机选择100例进行研究,随机分为两组,分别给予常规对症治疗和降尿酸治疗。结果经统计和比较,治疗前两组患者的血尿酸水平差异不显著,(P>0.05);治疗后,观察组的血尿酸水平下降为(343±152)μmol/L,显著低于对照组的(456±161)μmol/L,差异有统计学意义,(P<0.05)。随访12个月,观察组的复发率为2.0%,显著低于对照组的36.0%,差异有统计学意义,(P<0.05)。结论临床治疗各种缺血性脑血管病的过程中,在常规治疗的基础上积极进行降尿酸治疗,可以有效减少复发的出现,提高预后。
目的:探討降尿痠治療對缺血性腦血管病預後的影響。方法從本院2010年10月-2012年10月收治的缺血性腦血管病患者中隨機選擇100例進行研究,隨機分為兩組,分彆給予常規對癥治療和降尿痠治療。結果經統計和比較,治療前兩組患者的血尿痠水平差異不顯著,(P>0.05);治療後,觀察組的血尿痠水平下降為(343±152)μmol/L,顯著低于對照組的(456±161)μmol/L,差異有統計學意義,(P<0.05)。隨訪12箇月,觀察組的複髮率為2.0%,顯著低于對照組的36.0%,差異有統計學意義,(P<0.05)。結論臨床治療各種缺血性腦血管病的過程中,在常規治療的基礎上積極進行降尿痠治療,可以有效減少複髮的齣現,提高預後。
목적:탐토강뇨산치료대결혈성뇌혈관병예후적영향。방법종본원2010년10월-2012년10월수치적결혈성뇌혈관병환자중수궤선택100례진행연구,수궤분위량조,분별급여상규대증치료화강뇨산치료。결과경통계화비교,치료전량조환자적혈뇨산수평차이불현저,(P>0.05);치료후,관찰조적혈뇨산수평하강위(343±152)μmol/L,현저저우대조조적(456±161)μmol/L,차이유통계학의의,(P<0.05)。수방12개월,관찰조적복발솔위2.0%,현저저우대조조적36.0%,차이유통계학의의,(P<0.05)。결론림상치료각충결혈성뇌혈관병적과정중,재상규치료적기출상적겁진행강뇨산치료,가이유효감소복발적출현,제고예후。
Objective To investigate the effect of urate lowering therapy on the prognosis of ischemic cerebrovascular disease. Methods Randomly selected from the hospital in 2010 October~2012 year in October were in patients with ischemic cerebrovas-cular disease 100 cases studied, were randomly divided into two groups, were given routine symptomatic treatment and urate lower-ing therapy. Results The statistics and comparison, the difference before treatment blood uric acid level in patients of the two groups was not significant (P>0.05), after treatment, the observation group; the serum uric acid level decreased to (343 ±152) μmol/L, significantly lower than the control group (456±161)μmol/L, the difference was statistically significant (P<0.05). After 12 months of follow-up, the recurrence rate in observation group was 2%, significantly lower than the control group 36%, the differ-ence was statistically significant (P<0.05). Conclusion The process of various clinical treatment of ischemic cerebrovascular dis-ease, in the conventional treatment based on positive urate lowering therapy, can effectively reduce the recurrence, improve prog-nosis.